2002
DOI: 10.1006/excr.2002.5638
|View full text |Cite
|
Sign up to set email alerts
|

Interactions of Opioid and Chemokine Receptors: Oligomerization of , and with CCR5 on Immune Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
83
0
2

Year Published

2004
2004
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 128 publications
(86 citation statements)
references
References 28 publications
1
83
0
2
Order By: Relevance
“…Both the opioids and chemokines mediate their effects on leukocytes through the activation of GPCR. Oligomerization of mu, kappa and delta opioid receptors with the chemokine receptor CCR5 on the cell membrane of human or monkey lymphocytes has been reported and suggests that opioid receptors interact with CCR5 in cells coexpressing both receptors (Suzuki et al, 2002). The kappa opioid receptor has been shown to regulate thymocyte C-C Chemokine receptor 2 expression (Zhang and Rogers 2000) and a kappa agonist inhibits monocyte chemoattractant protein-1 (CCL2) production by human astrocytes (Sheng et al, 2003) and SDF-1alpha receptor CXCR4 expression on CD4+ lymphocytes (Lokensgard et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Both the opioids and chemokines mediate their effects on leukocytes through the activation of GPCR. Oligomerization of mu, kappa and delta opioid receptors with the chemokine receptor CCR5 on the cell membrane of human or monkey lymphocytes has been reported and suggests that opioid receptors interact with CCR5 in cells coexpressing both receptors (Suzuki et al, 2002). The kappa opioid receptor has been shown to regulate thymocyte C-C Chemokine receptor 2 expression (Zhang and Rogers 2000) and a kappa agonist inhibits monocyte chemoattractant protein-1 (CCL2) production by human astrocytes (Sheng et al, 2003) and SDF-1alpha receptor CXCR4 expression on CD4+ lymphocytes (Lokensgard et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, coexpression of ␣ 2A AR with -OPR results in enhanced -OPR signaling in the absence of ␣ 2A AR agonist stimulation, with this effect being abolished following treatment of ␣ 2 AR agonists (Jordan et al, 2003). Finally, all three OPR subtypes have been found to interact in immune cells with the chemokine receptor CCR5 (Suzuki et al, 2002;Chen et al, 2004), with these interactions contributing to cross-desensitization between opioids and chemokines (Chen et al, 2004).…”
Section: Opioid Receptorsmentioning
confidence: 99%
“…The synergism suggests that naloxone and morphine produce analgesia in the NY1DD mouse via different receptor systems (16). Among the numerous possibilities that could give rise to synergism are the existence of chemokine/opioid heterodimeric receptors (18,19), which may selectively recognize naloxone in Naloxone and morphine tail-flick response was measured at the time of peak analgesic activity (10, 10, and 30 min, respectively). Values for morphine apply only to NY1DD mice.…”
Section: Effect Of Opioid Antagonists and Morphine On Ny1dd And Hberk1mentioning
confidence: 99%